Erlotinib Completed Phase 2 Trials for Fallopian Tube Cancer / Clear Cell Mullerian Tumor / Cancer of the Ovary / Primary Peritoneal Cancer / Papillary Serous Mullerian Tumor Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00520013Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors